E-Ink screens in ERs could boost patient satisfaction
NCT ID NCT04497922
First seen Jul 17, 2026 · Last updated Jul 17, 2026
Summary
This trial tests whether a virtual white board — an e-ink screen that shows patient status, care team information, and pending tests — can improve how satisfied patients feel during their emergency department stay. The study includes adults expected to stay at least four hours in the ER. Researchers compare the screen to standard communication to see if it improves satisfaction and the quality of information patients receive.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- an e-ink screen that displays patient status, care team info, and pending tests
- What this could lead to
- If effective, this simple tool could improve patient communication and satisfaction in busy emergency departments.
- What could go wrong
- This is a small, single-site study, and satisfaction is subjective; results may not apply to other hospitals or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a 15-Minute chat at a testing site boost COVID-19 vaccination?
- Could a single abutment placement save your jawbone?
- Massive study tracks how lockdowns shaped mental health across america
- Hidden danger: study probes blood clot risk in cancer patients with COVID-19
- Experimental drug aims to tame severe COVID-19 inflammation
- Study seeks to unlock secrets of penile implant pump misuse